Cigna CorpCI
▲ PositiveCapitalrelevance
Article states Cigna stock is undervalued with a P/E of 12.1x vs fair P/E of 28.6x, indicating a cheap valuation based on earnings.
Impact on stocks 1
Health Care
Cigna CorpCigna Group stock still screens as undervalued on earnings, with a current price-to-earnings multiple of about 12.1 times, less than half the Healthcare industry average of 25.9 times and well below the peer average of 44.5 times. The model-based fair P/E for Cigna Group is 28.6 times, more than double the current multiple, indicating a sizeable gap between the price and what would be expected given its profile. The company now leans heavily on the Evernorth health services engine, including new AI-powered pharmacy programs, rather than just traditional insurance. The key issue for investors is whether the apparent undervaluation reflects a genuine opportunity or simply matches the risks seen in the business mix and outlook, particularly around execution of Evernorth initiatives and sustained cash generation.
Cigna CorpArticle states Cigna stock is undervalued with a P/E of 12.1x vs fair P/E of 28.6x, indicating a cheap valuation based on earnings.